Kineret and Tinnitus - a phase IV clinical study of FDA data

Summary:

Tinnitus is reported as a side effect among people who take Kineret (anakinra), especially for people who are female, 50-59 old, also take Ilaris, and have Juvenile rheumatoid arthritis.

The phase IV clinical study analyzes which people have Tinnitus when taking Kineret. It is created by eHealthMe based on reports of 11,092 people who have side effects when taking Kineret from the FDA, and is updated regularly.

What is Kineret?

Kineret has active ingredients of anakinra. It is often used in rheumatoid arthritis. eHealthMe is studying from 11,120 Kineret users. Check the latest studies of Kineret.

What is Tinnitus?

Tinnitus (a ringing in the ears) is found to be associated with 1,668 drugs and 3,065 conditions by eHealthMe. Check the latest studies of Tinnitus.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 22, 2026

11,092 people reported to have side effects when taking Kineret.
Among them, 17 people (0.15%) have Tinnitus.

Among these 17 people:

What is the gender of people who have Tinnitus when taking Kineret? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Tinnitus when taking Kineret? *

What are other drugs people take besides Kineret? *

What are other side effects people have besides Tinnitus? *

Nausea (feeling of having an urge to vomit): 8 people, 47.06%
Headache (pain in head): 7 people, 41.18%
Fatigue (feeling of tiredness): 4 people, 23.53%
Weakness: 4 people, 23.53%
Dizziness: 3 people, 17.65%
The Flu (the flu is caused by an influenza virus): 3 people, 17.65%
Insomnia (sleeplessness): 3 people, 17.65%
Neuropathy Peripheral (surface nerve damage): 3 people, 17.65%
Weight Increased: 2 people, 11.76%
Pain In Extremity: 2 people, 11.76%

What are the existing conditions these people have? *

Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 3 people, 17.65%
Prostatomegaly (enlargement of the prostate): 1 person, 5.88%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 5.88%
Polychondritis (progressive inflammation of cartilage and other connective tissue): 1 person, 5.88%
Pericardial Disease: 1 person, 5.88%
Meniere's Disease (a disorder of the inner ear that can affect hearing and balance to a varying degree): 1 person, 5.88%
Joint Pain: 1 person, 5.88%
Immune System Disorder: 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
Hepatitis C: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Kineret and have Tinnitus?

- Check whether Tinnitus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kineret:

Kineret (11,120 reports)

Tinnitus treatments and more:

Tinnitus (58,552 reports)

Browse all side effects of Kineret:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tinnitus:

Tinnitus (1,668 drugs)

Browse all the conditions that are associated with Tinnitus:

Tinnitus (3,065 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on anakinra (the active ingredients of Kineret) and Kineret (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.